The raphe nuclei have a vast impact upon the central nervous system. Many of the neurons in the nuclei (but not the majority) are serotonergic; i.e., contain
serotonin, a type of
monoamine neurotransmitter and are modulated through fibrous pathways in the midbrain. Projections from the raphe nuclei also terminate in the dorsal horn of spinal gray matter where they regulate the release of
enkephalins, which inhibit pain sensation. The raphe nuclei provide feedback to the
suprachiasmatic nuclei (SCN), thus contributing in circadian rhythms in animals. The SCN transmits to the raphe nuclei via the
dorsomedial hypothalamic nucleus altering serotonin levels for sleep/wake states. The raphe nuclei will then transmit feedback to the SCN about the animal's vigilance and levels of alertness. This reciprocal feedback between the two structures provides an adaptable yet stable basis of circadian rhythms.
Thermoregulation A large increase in sympathetic nerve activity was observed when an excitatory amino acid was injected into the
raphe pallidus, resulting in both brown adipose tissue (BAT) temperature and heart rate increasing. This suggests that activation of the raphe nucleus results in an increase in sympathetic activity to the BAT. The raphe pallidus wasn't switched off using 8-OH-DPAT, which in turn reduced body temperature due to a reduced response to cold. This suggests the importance of the raphe nucleus in responding appropriately to the cold.
Sleep and arousal regulation According to Michel Jouve from Lyon, there is a contradiction in study findings regarding the relationship between serotonin and sleep: initially, serotonin was believed to act as a neuromodulator of sleep, as destruction of serotonergic neurons in the raphe nuclei or inhibition of serotonin synthesis induced severe insomnia. However, studies showed that the electrical activity of serotonergic cell bodies and serotonin release increases during wakefulness and decreases during sleep, which appears at first glance to contradict the idea of serotonin contributing to sleep. For the same author, serotonin release during wakefulness can trigger a cascade of genomic events in some sleep-promoting neurons in the preoptic area, allowing it under certain conditions to also contribute to increased sleep propensity and regulation of slow-wave sleep, According to Monti from Uruguay, who based his conclusions on electrophysiological, neurochemical, genetic, and neuropharmacological approaches, serotonin (5-HT) originating from the dorsal raphe nucleus primarily promotes wakefulness and inhibits rapid eye movement (REM) sleep, the stage during which dreaming occurs. For Barbara Estone Jones, Serotonergic raphe neurons promote a seemingly quiet or satiated waking state, which though exclusive of REMS, can actually be conducive to SWS
The raphe nuclei and the effects of ghrelin More recent studies of the Raphe Nuclei done with rats involve the effects of
ghrelin on the
dorsal raphe nucleus. When administered, larger doses of ghrelin act centrally on the raphe nucleus,
hippocampus, and
amygdala which causes dramatic increases in food intake, memory retention, and increases in anxiety. The effects of ghrelin are seen on the raphe nucleus as soon as an hour after injection, suggesting rapid changes in the structure of the nucleus. Changes also occur after 24 hours suggesting delayed modifications as well. == See also ==